Artiva Biotherapeutics CEO Aslan Fred sells $690K in shares
Aslan Fred, a director and Chief Executive Officer, sold 61,888 shares in an automatic sell-to-cover under a reported Form 4 filing. Weighted average sale price was $11.1555 per share, totaling $690,391.
Aslan Fred, a director and Chief Executive Officer, sold shares under a reported Form 4 filing.
The weighted average sale price was $11.1555 per share and the total sale amount was $690,391.
The sale comprised 61,888 shares disposed of in an automatic sell-to-cover to satisfy tax withholding relate…